Page last updated: 2024-08-23

levamisole and 2019 Novel Coronavirus Disease

levamisole has been researched along with 2019 Novel Coronavirus Disease in 5 studies

Research

Authors	Studies
Kapila, R; Keim, CK; Schwartz, RA	1
Bernardi, S; Boyer, O; Charbit, M; Innocenti, S	1
Güllü, İ; Güven, GS; Uyaroğlu, OA	1
Logan, BK; Midthun, KM; Nelson, LS	1
Al-Gareeb, AI; Al-Kuraishy, HM; Alexiou, A; Alkazmi, L; Batiha, GE	1

2 review(s) available for levamisole and 2019 Novel Coronavirus Disease

Article	Year
Levamisole-induced and COVID-19-induced retiform purpura: two overlapping, emerging clinical syndromes. Archives of dermatological research, 2023, Volume: 315, Issue:2 Topics: COVID-19; Humans; Levamisole; Purpura	2023
Levamisole-a Toxic Adulterant in Illicit Drug Preparations: a Review. Therapeutic drug monitoring, 2021, 04-01, Volume: 43, Issue:2 Topics: Cocaine; COVID-19; Female; Fentanyl; Heroin; Humans; Illicit Drugs; Infant, Newborn; Levamisole; Pregnancy; Prenatal Exposure Delayed Effects; SARS-CoV-2; United States	2021

3 other study(ies) available for levamisole and 2019 Novel Coronavirus Disease

Article	Year
Late Onset of ANCA Vasculitis as a Side Effect of Levamisole Treatment in Nephrotic Syndrome. Medicina (Kaunas, Lithuania), 2022, May-11, Volume: 58, Issue:5 Topics: Antibodies, Antineutrophil Cytoplasmic; Arthritis; Celiac Disease; Child, Preschool; COVID-19; COVID-19 Vaccines; Humans; Levamisole; Male; Neoplasm Recurrence, Local; Nephrotic Syndrome; Vasculitis	2022
Can Levamisole be used in the treatment of COVID-19 patients presenting with diarrhea? Journal of infection in developing countries, 2020, Aug-31, Volume: 14, Issue:8 Topics: Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Diarrhea; Humans; Immunologic Factors; Levamisole; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Levamisole Therapy in COVID-19. Viral immunology, 2021, Volume: 34, Issue:10 Topics: COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Humans; Levamisole; Lung; SARS-CoV-2	2021